cGMP


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

cGMP

abbr.
cyclic GMP

cGMP

cyclic GMP.
Mentioned in ?
References in periodicals archive ?
Dubbed "Flamma-delphia" for now, this lab and manufacturing site has a cGMP pilot plant with hydrogenation capabilities as well as wet-milling, 6 standard cGMP kilo lab suites, 1 cGMP HPAPI kilo lab suite with isolators that have been classified 3b (Roche) or band 4 (Safebridge), 22 fume hoods, an analytical development lab as well as a QC lab, and additional space for future expansion for any necessary analytical, chemistry, and/ or warehouse needs.
The FDA inspection at Life Rising found that its dietary supplements were prepared, packed, and/or held under conditions that violated CGMP regulations.
Biologics technology company WuXi Biologics (stock code:2269.HK) reported on Monday the receipt of European Medicines Agency (EMA) Pre-Approval Inspection (PAI) for its cGMP Drug Substance (DS) and Drug Product (DP) manufacturing facilities with no critical findings.
The cGMP configuration allows pharmacies to implement RIVA's safe and efficient compounding process to manufacture a wide range of medications.
Velesco provides fast and cost-effective contract analytical development and drug formulation services along with cGMP clinical supplies offering a full range of non-sterile dosage forms.
The first tissues were processed in August 2017 when the cGMP manufacturing suite officially opened after a 2-year construction and remodeling effort and nearly a decade of iPSC reprogramming research and optimization.
To conclude this cGMP comparison series, I will focus on ways 21 CFR Part 820 Quality System Regulation, also known as the cGMP regulation for medical devices, aligns with the cGMP requirements of 21 CFR Part 211 Subpart E--Control of Components and Drug Product Containers and Closures.
It explains when facilities are exempt from CGMP or preventive controls requirements because they are "solely engaged" in certain activities.
Scope and applicability are adequately described in both the pharmaceutical and medical device cGMP regulations, specifically in sections 210.1 and 210.2 and in 211 Subpart A--General Provisions for pharmaceuticals; in section 211.1 Scope; and Subpart A--General Provisions for medical devices, specifically 820.1 Scope.
Briefly, the PDE assay was started by adding substrate (cGMP, 10 [micro]M final concentration) to the reaction mixture containing PDE buffer and a known amount of tissue homogenate.
Lynen, "Wounding stress causes rapid increase in concentration of the naturally occurring 2',3'-isomers of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in plant tissues," Phytochemistry, vol.
To gain an understanding of current Regulatory requirements for CGMP compliance for OTC drugs in the U.S.;